JP2024524273A5 - - Google Patents
Info
- Publication number
- JP2024524273A5 JP2024524273A5 JP2023579334A JP2023579334A JP2024524273A5 JP 2024524273 A5 JP2024524273 A5 JP 2024524273A5 JP 2023579334 A JP2023579334 A JP 2023579334A JP 2023579334 A JP2023579334 A JP 2023579334A JP 2024524273 A5 JP2024524273 A5 JP 2024524273A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- dose
- weeks
- week
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110711050.0 | 2021-06-25 | ||
| CN202110711050 | 2021-06-25 | ||
| PCT/CN2022/100878 WO2022268174A1 (zh) | 2021-06-25 | 2022-06-23 | Mazdutide的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524273A JP2024524273A (ja) | 2024-07-05 |
| JP2024524273A5 true JP2024524273A5 (cg-RX-API-DMAC10.html) | 2025-06-30 |
Family
ID=84544128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023579334A Pending JP2024524273A (ja) | 2021-06-25 | 2022-06-23 | マズチドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240293513A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4360641A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024524273A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240027053A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117597135A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022298841A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3224043A1 (cg-RX-API-DMAC10.html) |
| TW (2) | TW202617173A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022268174A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023281591A1 (en) * | 2022-06-01 | 2025-01-02 | Innovent Biologics (Suzhou) Co., Ltd. | Treatment method using mazdutide |
| EP4788362A1 (en) * | 2023-10-03 | 2026-08-12 | Innovent Biologics (Suzhou) Co., Ltd. | Methods of treating diabetes and obesity |
| EP4788356A1 (en) * | 2023-10-03 | 2026-08-12 | Innovent Biologics (Suzhou) Co., Ltd. | Methods of treating adolescent obesity |
| WO2025098422A1 (zh) * | 2023-11-07 | 2025-05-15 | 深圳信立泰药业股份有限公司 | 多重受体共激动剂化合物及其制备方法与应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0511986D0 (en) * | 2005-06-13 | 2005-07-20 | Imp College Innovations Ltd | Novel compounds and their effects on feeding behaviour |
| TWI783244B (zh) * | 2015-06-22 | 2022-11-11 | 美商美國禮來大藥廠 | 升糖素及glp-1共激動劑化合物 |
| WO2019171352A2 (en) * | 2018-03-08 | 2019-09-12 | Janssen Pharmaceutica Nv | Methods of treating severe non-diabetic obesity |
| AU2023281591A1 (en) * | 2022-06-01 | 2025-01-02 | Innovent Biologics (Suzhou) Co., Ltd. | Treatment method using mazdutide |
-
2022
- 2022-06-23 TW TW114124620A patent/TW202617173A/zh unknown
- 2022-06-23 CA CA3224043A patent/CA3224043A1/en active Pending
- 2022-06-23 US US18/573,602 patent/US20240293513A1/en active Pending
- 2022-06-23 TW TW111123396A patent/TW202300171A/zh unknown
- 2022-06-23 KR KR1020247003005A patent/KR20240027053A/ko active Pending
- 2022-06-23 WO PCT/CN2022/100878 patent/WO2022268174A1/zh not_active Ceased
- 2022-06-23 AU AU2022298841A patent/AU2022298841A1/en active Pending
- 2022-06-23 CN CN202280045316.5A patent/CN117597135A/zh active Pending
- 2022-06-23 JP JP2023579334A patent/JP2024524273A/ja active Pending
- 2022-06-23 EP EP22827666.3A patent/EP4360641A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12629347B2 (en) | Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases | |
| JP2010525078A5 (cg-RX-API-DMAC10.html) | ||
| CN1178696C (zh) | 含人体生长激素和皮质甾醇合成抑制剂的用于治疗代谢综合症的制剂 | |
| RU2012110592A (ru) | Соединения и способ снижения мочевой кислоты | |
| JP2019515884A5 (cg-RX-API-DMAC10.html) | ||
| CN113301889A (zh) | Nafld和nash的联合治疗 | |
| TWI908718B (zh) | 類鐸受體促效劑給藥方案 | |
| JP2022533981A5 (cg-RX-API-DMAC10.html) | ||
| US20210260025A1 (en) | Capsid assembly modulator dosing regimen | |
| WO2019046287A1 (en) | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HEPATITIS B | |
| JP2018532797A5 (cg-RX-API-DMAC10.html) | ||
| JP2022554276A5 (cg-RX-API-DMAC10.html) | ||
| JPWO2023054732A5 (cg-RX-API-DMAC10.html) | ||
| JP2022533968A5 (cg-RX-API-DMAC10.html) | ||
| JP2024527023A5 (cg-RX-API-DMAC10.html) | ||
| MX2014000971A (es) | Agente mejorador de la funcion diastolica ventricular izquierda. | |
| BRPI0610873A2 (pt) | tratamento de doenças hepáticas em que o ferro desempenhe um papel na patogênese | |
| CN113784717A (zh) | 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药 | |
| JP6202633B2 (ja) | ハロフェナートまたはハロフェン酸および第２の尿酸低下薬を用いる痛風に罹っている患者の高尿酸血症の治療方法 | |
| JP2002504138A (ja) | ロシグリタゾンおよびインスリンを用いる糖尿病の治療 | |
| JP2024520020A5 (cg-RX-API-DMAC10.html) | ||
| JP2023502053A5 (cg-RX-API-DMAC10.html) | ||
| JP2006524190A5 (cg-RX-API-DMAC10.html) | ||
| JP6047172B2 (ja) | 患者部分集団における痛風の治療方法 | |
| CN113557016A (zh) | 衣壳组装调节剂固体配制品 |